Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Study Assessing Ophthalmic Safety in Patients With Breast Cancer

NCT06767462 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06767462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06767462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Study Assessing Ophthalmic Safety in Patients With Breast Cancer
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Active, not recruiting
Start date
March 5, 2025
Completion date
April 9, 2027
Enrollment
160 (estimated)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

ophthalmic safety in patients with breast cancer